OPKO Health, Inc., 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 20,814 shares at $8.54 ($178K) on 2013-11-26, disclosed to the SEC on 2013-11-27.
Open-market sale of $178k SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.54 | 12,100 | $103K | 58.1% |
| 2 | $8.54 | 8,714 | $74K | 41.9% |
| Total | $8.54 avg | 20,814 | $178K | 100% |
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |